Ronald van Vollenhoven

Professor and Chief

Amsterdam UMC

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (14)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (19)

Alexandre Voskuyl

Professor of Rheumatology

VU Amsterdam

NETHERLANDS

View details

Anne Gitte Loft

Aarhus University

DENMARK

View details

Zahi Touma

University Health Network

CANADA

View details

Merete Lund Hetland

Professor

University of Copenhagen

DENMARK

View details

Ian N Bruce

The University of Manchester

UNITED KINGDOM

View details

Giovanni Cagnotto

Lund University

SWEDEN

View details

Anna-Mari Hokkanen

Helsinki University Hospital

FINLAND

View details

Roy Fleischmann

Clinical Professor of Medicine

University of Texas Southwestern Medical Center

UNITED STATES

View details

Kristina Lend

Karolinska Institutet

SWEDEN

View details

Mikkel Østergaard

Professor

Rigshospitalet

DENMARK

View details

Filip Eftimov

NETHERLANDS

View details

Anca D. Askanase

Columbia University Irving Medical Center

UNITED STATES

View details

Line Uhrenholt

Aalborg University

DENMARK

View details

Luís Sousa Inês

Assistant Professor

University of Coimbra

PORTUGAL

View details

Rosemary Hollick

University of Aberdeen

UNITED KINGDOM

View details

Hanne Merete Lindegaard

University of Southern Denmark

DENMARK

View details

Victoria P. Werth

UNITED STATES

View details

Eric Morand

MONASH UNIVERSITY

AUSTRALIA

View details

Lucía Otero Varela

Profesora

Universidad CEU San Pablo

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Ronald van Vollenhoven

Research Interests

Explore related searches

Contact this professor

Articles (14)

Sex differences in patient-reported outcome measures and the association with clinical factors in axial spondyloarthritis patients treated with tumour necrosis factor inhibitors

Long-term sustainability of response to upadacitinib among patients with active rheumatoid arthritis refractory to biological treatments: results up to 5 years from SELECT-BEYOND

Obesity is a risk factor for poor response to treatment in early rheumatoid arthritis: a NORD-STAR study

Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial

Certolizumab pegol, abatacept, tocilizumab or active conventional treatment in early rheumatoid arthritis: 48-week clinical and radiographic results of the investigator-initiated randomised controlled NORD-STAR trial

Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance physician registry”

Clinical evaluation of optical spectral transmission imaging for detection of disease activity in rheumatoid arthritis

Meeting report: the ALPHA project: a stakeholder meeting on lupus clinical trial outcome measures and the patient perspective

Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trials

An ultrasound negative for subclinical synovitis in arthralgia patients: is it helpful in identifying those not developing arthritis?

Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus

Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study

Baricitinib decreases anti-dsDNA in patients with systemic lupus erythematosus: results from a phase II double-blind, randomized, placebo-controlled trial

Biological impact of iberdomide in patients with active systemic lupus erythematosus

Collaborators (19)

Alexandre Voskuyl

Anne Gitte Loft

Zahi Touma

Merete Lund Hetland

Ian N Bruce

Giovanni Cagnotto

Anna-Mari Hokkanen

Roy Fleischmann

Kristina Lend

Mikkel Østergaard

Filip Eftimov

Anca D. Askanase

Line Uhrenholt

Luís Sousa Inês

Rosemary Hollick

Hanne Merete Lindegaard

Victoria P. Werth

Eric Morand

Lucía Otero Varela

Make your next move.